• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高敏C反应蛋白是非酒精性脂肪性肝病的有力预测指标。

High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease.

作者信息

Yeniova Abdullah Ozgür, Küçükazman Metin, Ata Naim, Dal Kürşat, Kefeli Ayşe, Başyiğit Sebahat, Aktaş Bora, Ağladioğlu Kadir, Akin Kadir Okhan, Ertugrul Derun Taner, Nazligül Yaşar, Beyan Esin

出版信息

Hepatogastroenterology. 2014 Mar-Apr;61(130):422-5.

PMID:24901154
Abstract

BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) is a clinical term that covers simple fatty liver (SFL) and non-alcoholic steatohepatitis (NASH), and high-sensitivity C-reactive protein (hs-CRP) is a marker of inflammation. The aim of the present study was to investigate the relationship between steatosis and hs-CRP in patients with ultrasonographically verified NAFLD.

METHODOLOGY

We examined 296 consecutive patients. NAFLD was detected by ultrasound (US). Patients with NAFLD who had an alanine aminotransferase (ALT) level of > 40 IU/mL were considered to have NASH and those with normal liver function test results were considered to have SFL. Patients who did not have NAFLD constituted the control group. The SFL, NASH and control groups were compared in terms of hs-CRP levels.

RESULTS

Of 296 patients, 86 had normal hepatic US findings and 210 had hepatosteatosis. Hs-CRP levels were higher in patients with NAFLD as compared to the control group (0.68 mg/ dL vs. 0.34 mg/dL, respectively; P < 0.05). There was no significant difference between patients with SFL and NASH in terms of hs-CRP levels (P > 0.05). Logistic regression analysis revealed that hs-CRP was a strong predictor of NAFLD (odds ratio: 6.04; 95% confidence interval: 2.08-17.74).

CONCLUSIONS

hs-CRP can be used as a non-invasive marker of NAFLD as it was found to be a strong predictor of NAFLD in this study.

摘要

背景/目的:非酒精性脂肪性肝病(NAFLD)是一个涵盖单纯性脂肪肝(SFL)和非酒精性脂肪性肝炎(NASH)的临床术语,而高敏C反应蛋白(hs-CRP)是炎症的一个标志物。本研究的目的是调查经超声检查证实的NAFLD患者中脂肪变性与hs-CRP之间的关系。

方法

我们检查了296例连续患者。通过超声(US)检测NAFLD。丙氨酸氨基转移酶(ALT)水平>40 IU/mL的NAFLD患者被认为患有NASH,肝功能检查结果正常的患者被认为患有SFL。没有NAFLD的患者构成对照组。比较SFL、NASH和对照组的hs-CRP水平。

结果

在296例患者中,86例肝脏超声检查结果正常,210例有肝脂肪变性。与对照组相比,NAFLD患者的hs-CRP水平更高(分别为0.68 mg/dL和0.34 mg/dL;P<0.05)。SFL和NASH患者之间的hs-CRP水平无显著差异(P>0.05)。逻辑回归分析显示,hs-CRP是NAFLD的一个强有力的预测指标(优势比:6.04;95%置信区间:2.08-17.74)。

结论

在本研究中,hs-CRP被发现是NAFLD的一个强有力的预测指标,因此可作为NAFLD的一种非侵入性标志物。

相似文献

1
High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease.高敏C反应蛋白是非酒精性脂肪性肝病的有力预测指标。
Hepatogastroenterology. 2014 Mar-Apr;61(130):422-5.
2
C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.肥胖患者中 C-反应蛋白水平与非酒精性脂肪性肝病各特征的关系。
J Hepatol. 2011 Sep;55(3):660-665. doi: 10.1016/j.jhep.2010.12.017. Epub 2011 Jan 14.
3
Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics.非酒精性脂肪性肝病及其与西班牙裔人群肥胖、胰岛素抵抗和血清C反应蛋白水平升高的关联。
Liver Int. 2009 Jan;29(1):82-8. doi: 10.1111/j.1478-3231.2008.01823.x. Epub 2008 Jul 16.
4
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.高敏C反应蛋白是非酒精性脂肪性肝炎(NASH)的一项独立临床特征,也是NASH中肝纤维化严重程度的独立临床特征。
J Gastroenterol. 2007 Jul;42(7):573-82. doi: 10.1007/s00535-007-2060-x. Epub 2007 Jul 25.
5
Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.非酒精性脂肪性肝炎患者血清细胞间黏附分子-1:与酒精性肝炎的比较
Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S83-7. doi: 10.1111/j.1530-0277.2006.00292.x.
6
[High-sensitivity C-reactive protein (hs-CRP): a promising biomarker for the screening of non-alcoholic steatohepatitis (NASH)].[高敏C反应蛋白(hs-CRP):一种用于筛查非酒精性脂肪性肝炎(NASH)的有前景的生物标志物]
Nihon Rinsho. 2006 Jun;64(6):1133-8.
7
Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.非酒精性脂肪性肝病患者血浆不对称二甲基精氨酸水平升高:与胰岛素抵抗、炎症及肝脏组织学的关系
J Investig Med. 2015 Oct;63(7):871-7. doi: 10.1097/JIM.0000000000000230.
8
High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.高正常水平的超敏C反应蛋白可预测健康男性非酒精性脂肪肝的发生。
PLoS One. 2017 Feb 24;12(2):e0172666. doi: 10.1371/journal.pone.0172666. eCollection 2017.
9
Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.高敏C反应蛋白在非胰岛素依赖型糖尿病合并非酒精性脂肪性肝病患者中的预后价值
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8494-9. eCollection 2015.
10
Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.内脏脂肪组织和炎症与超重和肥胖患者队列中肝酶升高相关。
Int J Obes (Lond). 2010 May;34(5):899-907. doi: 10.1038/ijo.2010.4. Epub 2010 Feb 9.

引用本文的文献

1
The role of C-reactive protein to lymphocyte ratio in NAFLD and mortality among NAFLD patients.C反应蛋白与淋巴细胞比值在非酒精性脂肪性肝病及非酒精性脂肪性肝病患者死亡率中的作用。
BMC Gastroenterol. 2025 May 1;25(1):327. doi: 10.1186/s12876-025-03924-w.
2
Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017-2018.美国成年人中hs-CRP/HDL-C指数与代谢功能障碍相关脂肪性肝病及晚期肝纤维化的非线性关联:来自2017 - 2018年美国国家健康与营养检查调查(NHANES)的见解
Sci Rep. 2025 Feb 3;15(1):4029. doi: 10.1038/s41598-025-88685-y.
3
Exploring the mechanism of berberine treatment for atherosclerosis combined with non-alcoholic fatty liver disease based on bioinformatic and experimental study.
基于生物信息学和实验研究探索小檗碱治疗动脉粥样硬化合并非酒精性脂肪性肝病的机制
PLoS One. 2024 Dec 19;19(12):e0314961. doi: 10.1371/journal.pone.0314961. eCollection 2024.
4
High levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver disease in non-obese people: a cross-sectional study.高水平的血清超敏 C 反应蛋白与非肥胖人群的非酒精性脂肪性肝病相关:一项横断面研究。
Eur J Med Res. 2024 Oct 15;29(1):496. doi: 10.1186/s40001-024-02065-2.
5
Ketogenic diet but not free-sugar restriction alters glucose tolerance, lipid metabolism, peripheral tissue phenotype, and gut microbiome: RCT.生酮饮食而非无蔗糖限制可改变葡萄糖耐量、脂代谢、外周组织表型和肠道微生物群:随机对照试验。
Cell Rep Med. 2024 Aug 20;5(8):101667. doi: 10.1016/j.xcrm.2024.101667. Epub 2024 Aug 5.
6
Surrogate markers in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎中的替代标志物。
Med Pharm Rep. 2021 Nov;94(Suppl No 3):S34-S37. doi: 10.15386/mpr-2511. Epub 2021 Nov 29.
7
1,25-Dihydroxycholecalciferol down-regulates 3-mercaptopyruvate sulfur transferase and caspase-3 in rat model of non-alcoholic fatty liver disease.1,25-二羟胆钙化醇下调非酒精性脂肪性肝病大鼠模型中的 3-巯基丙酮酸硫转移酶和半胱天冬酶-3。
J Mol Histol. 2023 Apr;54(2):119-134. doi: 10.1007/s10735-023-10118-9. Epub 2023 Mar 17.
8
Fermented Soybean Paste Attenuates Biogenic Amine-Induced Liver Damage in Obese Mice.发酵大豆酱可减轻肥胖小鼠生物胺诱导的肝损伤。
Cells. 2023 Mar 6;12(5):822. doi: 10.3390/cells12050822.
9
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives.了解非酒精性脂肪性肝病:从病例识别到干预、结局和未来展望。
Nutrients. 2023 Jan 29;15(3):687. doi: 10.3390/nu15030687.
10
Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)-A Pilot Study.肥胖症非酒精性脂肪性肝病(NAFLD)患者唾液中促炎脂肪因子和细胞因子谱:一项初步研究。
Int J Mol Sci. 2023 Feb 2;24(3):2891. doi: 10.3390/ijms24032891.